Skip to content

EBITDA at other companies

IAR
Integra LifeSciencesIART
$53.68M+111%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.39M-38.5%
iRadimed logo
iRadimedIRMD
$7.69M+36.7%
Teladoc Health logo
Teladoc HealthTDOC
$28.06M+177%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
-$32.78M-75.2%
Cerence Inc. logo
Cerence Inc.CRNC
$347K-98.3%

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

$20.7Mebit+
$239.0KDepreciation Depletion & Amortization
=-$20.51M

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s EBITDA?
CeriBell, Inc. (CBLL) reported EBITDA of -$20.51M in Q1 2026.
How has CeriBell, Inc.'s EBITDA changed year-over-year?
CeriBell, Inc.'s EBITDA decreased by 47.8% year-over-year, from -$13.87M to -$20.51M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.